You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 07/25/2014

Company Name Symbol %Change
CASTLE BRAND ROX
20.00%
NEWPARK RESO NR
14.92%
ROYAL BK SC- RBS
10.73%
ECHO GLOBAL ECHO
7.71%
UNIVL HLTH S UHS
6.86%

Tale of the Tape

Spectranetics (SPNC) in Focus: Stock Rises 6.1%

Posted Fri Jul 25, 09:46 am ET

by Zacks Equity Research

The Spectranetics Corporation (SPNC) was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained nearly 14% in the past one-month time frame.

This developer of single-use medical devices for use in minimally invasive cardiovascular procedures has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Spectranetics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some notable stocks in the medical instruments industry are Heartware International Inc. (HTWR), IDEXX Laboratories, Inc. (IDXX) and Sirona Dental Systems Inc. (SIRO). All the three stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Exelixis (EXEL) Jumps: Stock Adds 11.4% in Session

Posted Fri Jul 25, 09:39 am ET

by Zacks Equity Research

Exelixis, Inc. (EXEL) was a big mover last session, as its shares rose over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $3.25 to $4.09 in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price rally is encouraging though, so make sure to keep an eye on this stock going forward.

Exelixis currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the broader medical sector include Actelion Ltd. (ALIOF), Biogen Idec Inc. (BIIB) and Curis, Inc. (CRIS). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Skechers USA (SKX) Jumps: Stocks Adds 8.0 % in session

Posted Fri Jul 25, 09:32 am ET

by Zacks Equity Research

Skechers USA Inc. (SKX) was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.This continues the recent uptrend of the company as the stock is now up 13.50% since Jul 16.

The company witnessed one upward revision in the past 30 days. The Zacks Consensus Estimate also moved higher over the same time frame, suggesting that more solid trading could be ahead for Skechers. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Skechers cariries a Zacks Rank #2 (Buy), while its Earnings ESP is positive.

Investors interested in the consumer goods sector may also consider stocks like ANTA Sports Products Limited (ANPDF), Brown Shoe Co. Inc. (BWS) and Iconix Brand Group, Inc. (ICON). All these stocks carry a Zacks Rank #2.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Zacks Rank #5 Additions for Friday

Posted Fri Jul 25, 09:30 am ET

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • Altisource Residential Corp ( RESI )
  • Baltic Trading Ltd ( BALT )
  • Bunge Ltd (BG )
  • Del Frisco's Restaurant Group Inc (DFRG)
  • EMC Insurance Group Inc. (EMCI)

View the entire Zacks Rank #5 List.

 

Zacks Rank #1 Additions for Friday

Posted Fri Jul 25, 09:30 am ET

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

  • Alleghany Corporation (Y)
  • American Capital Agency Corp. (AGNC)
  • Apollo Residential Mortgage Inc (AMTG)
  • Itau Unibanco Holding SA (ITUB)
  • Benchmark Electronics, Inc. (BHE)

View the entire Zacks Rank #1 List.

 

Healthways (HWAY) Jumps: Stock Moves 13.0% Higher

Posted Fri Jul 25, 09:25 am ET

by Zacks Equity Research

Healthways Inc. (HWAY) was a big mover last session with its shares rising almost 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $15.82 to $17.80.
 
This provider of specialized health solutions has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Healthways currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Investors interested in the medical devices industry may also consider stocks like PAREXEL International Corporation (PRXL), Quintiles Transnational Holdings Inc. (Q) and Omnicare Inc. (OCR). While PAREXEL sports a Zacks Rank #1, Quintiles Transnational and Omnicare bear a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

QR Energy, LP (QRE) Jumps: Stock Adds 9.1% in Session

Posted Fri Jul 25, 09:11 am ET

by Zacks.com

QR Energy, LP (QRE) was a big mover last session, as the company saw its shares rise over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 11.18% over the last 7 days.

The company has seen no estimate revisions in the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for QR Energy. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

QR Energy currently sports a Zacks Rank #1 (Strong Buy) with a negative Earnings ESP.

Some other stocks worth considering in the oil and gas industry include Callon Petroleum Company (CPE), EXCO Resources Inc. (XCO) and Midstates Petroleum Company, Inc. (MPO). Each of these stocks sports the same Zacks Rank as QR Energy.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Royal Caribbean Cruises (RCL) Jumps: Stock Rises 7.7%

Posted Fri Jul 25, 09:04 am ET

by Zacks Equity Research

Royal Caribbean Cruises Ltd. (RCL) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $53.92 to $57.13 in the past one-month time frame.

The company has seen no estimate revision in the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead for Royal Caribbean. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Royal Caribbean Cruises currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Other companies engaged in leisure and recreation services include Dover Motorsports Inc. (DVD), International Speedway Corp. (ISCA) and Manchester United plc (MANU). All these stocks have a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Quidel (QDEL) Falls: Stock Goes Down 7%

Posted Fri Jul 25, 08:59 am ET

by Zacks Equity Research

Quidel Corp. (QDEL) saw a big move last session, as the company’s shares fell by about 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a volatile range of $21.02–$25.33 in the past one-month time frame, showed a sharp decline yesterday at $23.55. 

This slump shouldn’t be too much of a surprise to investors, as this diagnostic healthcare provider has seen 3 negative revisions in the past few weeks and its current year loss consensus has moved wider over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

QDEL currently has a Zacks Rank #4 (Sell).

Some better-ranked stocks in the Medical Products industry include Alere Inc. (ALR), Cardiovascular Systems Inc. (CSII) and CareFusion Corporation (CFN). All these stocks hold  a Zacks Rank #1 (Strong Buy). 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 DaysClick to get this free report >>
 
 

Is a Surprise Coming for AXIS Capital Holdings (AXS) This Earnings Season?

Posted Fri Jul 25, 08:58 am ET

by Zacks Equity Research

Investors are always looking for stocks that are poised to beat at earnings season and AXIS Capital Holdings Limited (AXS) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because AXIS Capital Holdings is seeing favourable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings—with the most up-to-date information possible—is a pretty good indicator of some favourable trends underneath the surface for AXS in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at $1.25 per share for AXS, compared to a broader Zacks Consensus Estimate of $1.22 per share. This suggests that analysts have very recently bumped up their estimates for AXS, giving the stock a Zacks Earnings ESP of 2.46% heading into earnings season.

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10 year back test shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that AXS has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings. Clearly, recent earnings estimate revisions suggest that good things are ahead for AXIS Capital Holdings, and that a beat might be in the cards for the upcoming report.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Full Archive

The content contained in this weblog feature may have been abstracted from a complete Zacks Equity Research report.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.